Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain

Genomics

Volumn 81, Issue 5, 2003, Pages 457-467

  Mao, Rong ^a   Zielke, Carol L ^b   Zielke, H Ronald ^b   Pevsner, Jonathan ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN EXTRACT;

ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; CHROMOSOME 21; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FETUS; GENE EXPRESSION REGULATION; GENE LOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PHENOTYPE; PRIORITY JOURNAL; UPREGULATION;

EID: 0037403505     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0888-7543(03)00035-1     Document Type: Article

References (33)

1. Jackson J.F., North E.R. 3rd, Thomas J.G. Clinical diagnosis of Down's syndrome. Clin. Genet. 9:1976;483-487.
2. Epstein C.J., et al. Protocols to establish genotype-phenotype correlations in Down syndrome. Am. J. Hum. Genet. 49:1991;207-235.
3. Lejeune J., Gautier M., Turpin R. Etudes des chromosomes somatique de neuf enfants mongoliens. C. R. Acad. Sci. Paris. 248:1959;1721-1722.
4. Jacobs P., Baikie W., Court-Brown W., Strong J. The somatic chromosomes in mongolism. Lancet. i:1959;710-711.
5. Shapiro B.L. Down syndrome - A disruption of homeostasis. Am. J. Med. Genet. 14:1983;241-269.
6. Shapiro B.L. Whither Down syndrome critical regions? Hum. Genet. 99:1997;421-423.
7. Korenberg J.R., et al. Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype. Am. J. Hum. Genet. 47:1990;236-246.
8. Antonarakis S.E. Chromosome 21 From sequence to applications . Curr. Opin. Genet. Dev. 11:2001;241-246.
9. Hattori M., et al. The DNA sequence of human chromosome 21. Nature. 405:2000;311-319.
10. C. Kiss, G. Ceresoli-Borroni, P. Guidetti, C.L. Zielke, H.R. Zielke, R. Schwarcz (2002). Kynurenate production by cultured human astrocytes, J. Neural Transm., in press.
11. Bouton C.M., Pevsner J. DRAGON Database referencing of array genes online . Bioinformatics. 16:2000;1038-1039.
12. Bouton C.M., Pevsner J. DRAGON view Information visualization for annotated microarray data . Bioinformatics. 18:2002;323-324.
13. Jackson J.E. A User's Guide to Principal Components. 1991;Wiley-Interscience, New York.
14. Antonarakis S.E., Lyle R., Chrast R., Scott H.S. Differential gene expression studies to explore the molecular pathophysiology of Down syndrome. Brain Res. Brain Res. Rev. 36:2001;265-274.
15. Bahn S., et al. Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome A gene expression study . Lancet. 359:2002;310-315.
16. Engidawork E., Lubec G. Protein expression in Down syndrome brain. Amino Acids. 21:2001;261-331.
17. Anderson L., Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis. 18:1997;533-537.
18. Gygi S.P., Rochon Y., Franza B.R., Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 19:1999;1720-1730.
19. Greenbaum D., Jansen R., Gerstein M. Analysis of mRNA expression and protein abundance data An approach for the comparison of the enrichment of features in the cellular population of proteins and transcripts . Bioinformatics. 18:2002;585-596.
20. Colantuoni C., Purcell A.E., Bouton C.M., Pevsner J. High throughput analysis of gene expression in the human brain. J. Neurosci. Res. 59:2000;1-10.
21. Kisling E. Cranial Morphology in Down's Syndrome A Comparative Roentgencephalometric Study in Adult Males . 1966;107 Munksgaard, Copenhagen.
22. Richtsmeier J.T., Baxter L.L., Reeves R.H. Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice. Dev. Dyn. 217:2000;137-145.
23. Lee S.C., Liu W., Brosnan C.F., Dickson D.W. Characterization of primary human fetal dissociated central nervous system cultures with an emphasis on microglia. Lab. Invest. 67:1992;465-476.
24. Lee S.C., Liu W., Roth P.I., Dickson D.W., Berman J.W., Brosnan C.F. Macrophage colony-stimulating factor in human fetal astrocytes and microglia. J. Immunol. 150:1993;594-604.
25. C. Colantuoni, G. Henry, S. Zeger, J. Pevsner (2002). SNOMAD (standardization and normalization of microarray data): Web-accessible gene expression data analysis. Bioinformatics, in press.
26. Epstein C.J., et al. Transgenic mice with increased Cu/Zn-superoxide dismutase activity Animal model of dosage effects in Down syndrome . Proc. Natl. Acad. Sci. USA. 84:1987;8044-8048.
27. Elson A., Levanon D., Weiss Y., Groner Y. Overexpression of liver-type phosphofructokinase (PFKL) in transgenic-PFKL mice Implication for gene dosage in trisomy 21 . Biochem. J. 299:1994;409-415.
28. Reeves R.H., et al. Astrocytosis and axonal proliferation in the hippocampus of S100b transgenic mice. Proc. Natl. Acad. Sci. USA. 91:1994;5359-5363.
29. Lamb B.T., et al. Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice [corrected]. Nat. Genet. 5:1993;22-30.
30. Sumarsono S.H., et al. Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice. Nature. 379:1996;534-537.
31. Bustin M., et al. Characterization of transgenic mice with an increased content of chromosomal protein HMG-14 in their chromatin. DNA Cell Biol. 14:1995;997-1005.
32. Smith D.J., et al. Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nat. Genet. 16:1997;28-36.
33. Chrast R., et al. Mice trisomic for a bacterial artificial chromosome with the single-minded 2 gene (Sim2) show phenotypes similar to some of those present in the partial trisomy 16 mouse models of Down syndrome. Hum. Mol. Genet. 9:2000;1853-1864.